MedinCell SA (MDCLF)
34.39
0.00 (0.00%)
USD |
OTCM |
May 14, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.153B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 393.0% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 35.82 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 62.50% |
Profile
| MedinCell SA is a pharmaceutical company, which engages in the development of injectable products in therapeutic areas. It focuses on combining its proprietary BEPO technology with active ingredients already known and marketed; it controls the regular delivery of a drug at the optimal therapeutic dose. The company was founded by Anh Nguyen and Christophe Douat on January 9, 2003 and is headquartered in Jacou, France. |
| URL | http://www.medincell.com |
| Investor Relations URL | N/A |
| HQ State/Province | Occitanie |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Jun. 16, 2026 (est.) |
| Last Earnings Release | Dec. 09, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| MedinCell SA is a pharmaceutical company, which engages in the development of injectable products in therapeutic areas. It focuses on combining its proprietary BEPO technology with active ingredients already known and marketed; it controls the regular delivery of a drug at the optimal therapeutic dose. The company was founded by Anh Nguyen and Christophe Douat on January 9, 2003 and is headquartered in Jacou, France. |
| URL | http://www.medincell.com |
| Investor Relations URL | N/A |
| HQ State/Province | Occitanie |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Jun. 16, 2026 (est.) |
| Last Earnings Release | Dec. 09, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |